Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Other financing activities (2021 - 2025)

Valion Bio has reported Other financing activities over the past 3 years, most recently at $104000.0 for Q4 2025.

  • For Q4 2025, Other financing activities rose 192.86% year-over-year to $104000.0; the TTM value through Dec 2025 reached -$926000.0, down 24.97%, while the annual FY2025 figure was $172000.0, N/A changed from the prior year.
  • Other financing activities for Q4 2025 was $104000.0 at Valion Bio, up from -$112000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $289000.0 in Q2 2021 and troughed at -$918000.0 in Q3 2021.
  • A 3-year average of -$112600.0 and a median of $74000.0 in 2021 define the central range for Other financing activities.
  • On a YoY basis, Other financing activities climbed as much as 192.86% in 2025 and fell as far as 192.86% in 2025.
  • Year by year, Other financing activities stood at -$918000.0 in 2021, then soared by 87.8% to -$112000.0 in 2024, then skyrocketed by 192.86% to $104000.0 in 2025.
  • Business Quant data shows Other financing activities for TIVC at $104000.0 in Q4 2025, -$112000.0 in Q4 2024, and -$918000.0 in Q3 2021.